Zydus gets USFDA approval for Icosapent Ethyl Capsules, 0.5 g and 1 g
Icosapent Ethyl Capsules, 0.5 g and 1 g had annual sales of $1,316 million in the US
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Tag
hypertriglyceridemia
Alembic Pharmaceuticals gets USFDA nod for Fenofibrate Capsules
They are indicated as adjunctive therapy to diet for the reduction of LDL-C, Total-C, Triglycerides and Apo B in adult patients…